These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 2772848
1. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate. Wong M, Helston LM, Wells PG. Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848 [Abstract] [Full Text] [Related]
2. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture. Miranda AF, Wiley MJ, Wells PG. Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268 [Abstract] [Full Text] [Related]
4. Pharmacological studies on the potentiation of phenytoin teratogenicity by acetaminophen. Lum JT, Wells PG. Teratology; 1986 Feb; 33(1):53-72. PubMed ID: 3738810 [Abstract] [Full Text] [Related]
5. Effects of N-acetylcysteine on fetal development and on phenytoin teratogenicity in mice. Wong M, Wells PG. Teratog Carcinog Mutagen; 1988 Feb; 8(2):65-79. PubMed ID: 2899918 [Abstract] [Full Text] [Related]
6. Effects of phorone and/or buthionine sulfoximine on teratogenicity of 5-fluorouracil in mice. Naya M, Mataki Y, Takahira H, Deguchi T, Yasuda M. Teratology; 1990 Mar; 41(3):275-80. PubMed ID: 2326751 [Abstract] [Full Text] [Related]
7. Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice. Ozolins TR, Siksay DL, Wells PG. J Pharmacol Exp Ther; 1996 May; 277(2):945-53. PubMed ID: 8627577 [Abstract] [Full Text] [Related]
8. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase. Wells PG, Zubovits JT, Wong ST, Molinari LM, Ali S. Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687 [Abstract] [Full Text] [Related]
10. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells. Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K. Oncol Res; 1995 Jun; 7(3-4):191-200. PubMed ID: 8555653 [Abstract] [Full Text] [Related]
11. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells. Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E. Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339 [Abstract] [Full Text] [Related]
12. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats. Manning BW, Franklin MR, Galinsky RE. Drug Metab Dispos; 1991 Jun; 19(2):498-502. PubMed ID: 1676661 [Abstract] [Full Text] [Related]
13. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors. Miller AC, Henderson BW. J Natl Cancer Inst; 1986 Aug; 77(2):505-10. PubMed ID: 3461211 [Abstract] [Full Text] [Related]
14. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio. Mitchell JB, Russo A, Biaglow JE, McPherson S. Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769 [Abstract] [Full Text] [Related]
15. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow. Ono K, Shrieve DC. J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662 [Abstract] [Full Text] [Related]
16. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice. Yu WK, Wells PG. Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664 [Abstract] [Full Text] [Related]
17. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish. Gallagher EP, Hasspieler BM, Di Giulio RT. Biochem Pharmacol; 1992 May 28; 43(10):2209-15. PubMed ID: 1350905 [Abstract] [Full Text] [Related]
18. Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds. Wells PG, Nagai MK, Greco GS. Toxicol Appl Pharmacol; 1989 Mar 01; 97(3):406-14. PubMed ID: 2609340 [Abstract] [Full Text] [Related]
19. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Kramer RA, Greene K, Ahmad S, Vistica DT. Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359 [Abstract] [Full Text] [Related]
20. The effect of L-buthionine-[S,R]-sulfoximine on the pancreas in mice. A model of weakening glutathione-based defense mechanisms. Lüthen RE, Neuschwander-Tetri BA, Niederau C, Ferrell LD, Grendell JH. Int J Pancreatol; 1994 Aug 15; 16(1):31-6. PubMed ID: 7528760 [Abstract] [Full Text] [Related] Page: [Next] [New Search]